IMGN853-0401

First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IMGN853 in Adults With Ovarian Cancer and Other FOLR1-Positive Solid Tumors


Fox Chase Cancer Center - Philadelphia
7604 Central Avenue Lower Level
Friends Hall Physicians Building
Philadelphia, PA 19111

Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
450 Brookline Ave., #SW-350
Boston, MA 02215

Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114
617-643-7996

Princess Margaret Hospital
610 University Avenue
Toronto, ON M5T 2M9
416-586-4800

Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center
410 West Tenth Avenue
Columbus, OH 43210
614-293-3196

Barbara Ann Karmanos Cancer Institute
3990 John R
Detroit, MI 48201
313-966-7218

Sarah Cannon Research Institute
250 25th Avenue North, Suite 110
Nashville, TN 37203

University of Kansas Medical Center Research Institute
Fairway, KS 66205
913-945-7552

Stephenson Cancer Center at the University of Oklahoma
1200 Children's Ave. Suite 10000
Oklahoma City, OK 73104
405-271-4272

University of Texas Health Science Center at San Antonio
7703 Floyd Curl Drive
San Antonio, TX 78229